Creatine abnormalities in schizophrenia and bipolar disorder

References 

1. Ben-Shachar D, Laifenfeld D. Mitochondria, synaptic plasticity, and schizophrenia. International Review of Neurobiology. 2004;59:273–296
   • MEDLINE
   • CrossRef
2. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM, et al. Proton spectroscopy of human brain: effects of age and sex. Progress in Neuropsychopharmacology & Biological Psychiatry. 1994;18:995–1004
   • MEDLINE
   • CrossRef
3. Frey BN, Stanley JA, Nery FG, Monkul ES, Nicoletti MA, Chen HH, et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo ¹H MRS study. Bipolar Disorders. 2007;9(Suppl 1):119–127
   • CrossRef
4. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine. 2000;13:129–153
   • MEDLINE
   • CrossRef
5. Gruber S, Frey R, Mlynarik V, Stadlbauer A, Heiden A, Kasper S, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by ¹H-MRS at 3 Tesla. Investigational Radiology. 2003;38:403–408
6. Kato T, Murashita J, Shioiri T, Hamakawa H, Inubushi T. Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy. Journal of Neuropsychiatry and Clinical Neuroscience. 1996;8:417–422
7. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, et al. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology (Berlin). 2005;178:17–26
8. Öngür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex. 2000;10:206–219
9. Prescot AP, de BFB, Wang L, Brown J, Jensen JE, Kaufman MJ, et al. In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magnetic Resonance in Medicine. 2006;55:681–686
10. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
11. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. Journal of Magnetic Resonance Imaging. 1999;9:711–716
12. Siegel BV, Buchsbaum MS, Bunney WE, Gottschalk LA, Haier RJ, Lohr JB, et al. Cortical–striatal–thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry. 1993;150:1325–1336
13. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry. 2005;10:900–919
    • MEDLINE
    • CrossRef
14. Theberge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. British Journal of Psychiatry. 2007;191:325–334
15. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry. 2003;64:663–667
16. Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophrenia Bulletin. 2003;29:831–843
    • MEDLINE
    • CrossRef